Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q3 Loss of 31c/Share

Go back to Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q3 Loss of 31c/Share
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 228.18 +1.06 (0.47%)
Previous Close $227.12    52 Week High $109.10 
Open $223.52    52 Week Low $31.38 
Day High $228.25    P/E N/A 
Day Low $220.23    EPS $-1.45 
Volume 749,413